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Abstract
Antioxidant activity of Pueraria tuberose DC, (PT) Leguminosae (Fabaceae) has already been reported by us and here
an active compound has been isolated and its action on expression of iNOS protein has been explored by using
LPS induced changes in attached rat peritoneal macrophage cell culture. The pure compound was isolated by col-
umn chromatography and its structure was characterized by spectral studies, which was identified as tuberosin
(5 hydroxy 3,4,7,3’,4’ pentamethoxy flavone). Its antioxidant capacity was determined and compared with alcoholic
extract as EC50 value for scavenging potential towards pre-generated monocation ABTS* radical, superoxide radi-
cals, hydroxyl radicals, metal chelation property and on lipid peroxidation. Further, rat peritoneal macrophages
were isolated, cultured and the attached macrophages were exposed to lipopolysaccharide (LPS) with different
concentrations of tuberosin (pretreatment for 30 min). After 17 h the released NO content, in culture supernatant,
was indirectly estimated as accumulated nitrite by Griess reagent. To understand the mechanism of action, the
extent of expression of inducible nitric oxide synthase genes, the iNOS protein was assessed in macrophage lysate
by using its antibody on western blot analysis. Tuberosin significantly scavenged all the species of FRs, described
above and it also inhibited the LPS induced release of NO and amount of iNOS protein in macrophages. All the
changes were significant and concentration dependent. Thus it could be suggested that tuberosin, is one of the
active principles of Pueraria tuberose, which directly scavenges various species of Free radicals (FRs) and also inhi-
bits LPS induced inflammatory changes in macrophages.
Background
In recent years, phyto-medicine is in great demand as
food supplement for age related chronic diseases,
because of their multi-targeted action and lesser side
effects [1] In fact, these diseases are associated with gen-
eration of excessive free radical (FR) [2] and associated
inflammation [3] and these herbal products are rich in
polyphenols, specially flavones and tannins. Therefore,
search for potent antioxidants with anti-inflammatory
potential has always been in demand. In various coun-
tries, these herbs are used as a component of their alter-
native system of medicine [4] and in Ayurveda, an
Indian system of medicine, medicinal plants are well
documented for their therapeutic claims, with records of
long clinical use, for prevention and management of sev-
eral metabolic disorders [5].
Pueraria tuberosa Linn (PT), Leguminosae (Fabaceae),
known as Bidaarikand [6] is an extensive perennial
climber, with palmately arranged leaves, blue colored
flowers and half inches thick bark [7], growing through-
out tropical parts of India, mostly in moist regions, mon-
soon forests and coastal tracts. Its tuberous root, which is
brown in color and slightly curved, is in clinical use for
rejuvenation therapy. Its microscopic picture reveals the
presence of prismatic calcium crystals and tanniniferous
cells. It’s major chemical constituents include flavones
[C-glycoside (5,7,3’,5’-tetrahydroxy-4’-methoxyflavone-3’-
O-a-Lrhamnopyranosyl1®3-O-b-D-galactopyranoside)],
Isoflavones (Puerarone), Coumstan (Tuberostan, Puer-
arostan) [8], Epoxychalcanol [Puetuberosanol], (3’-
hydroxy-4’-phenoxy-a,b-epoxychalcan-a’ol)] [9], Ptero-
carpanoids [Hydroxytuberosin, Anhydroxytuberosin
(3-O-methylanhydrotuberosin)] [10], and Tuberosin [11].
The powder of PT root-tubers are in clinical use as anti-
aging and also as tonic, aphrodisiac, demulcent, lactago-
gue, purgative, cholagogue and also in scorpion sting.
Besides, it is also useful in emaciation of children, debility
and poor digestion [6,7]. Other investigators have
reported it for skin care, as anti-fertility [12]. One of its
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phytochemical, purerin, has been associated with anti-
diabetic property [13].
The presence of free transition metals in the biological
system leads to excessive generation of free radicals [14].
However when the natural antioxidant enzymes are not
sufficient to scavenge these active FRs, then their unu-
sual longer persistence in the cell, causes peroxidation
of cellular lipids and proteins, which results to damage
of cell-organelles. Further these oxidized macromole-
cules behave as foreign proteins and affect the immune
system. They may activate the inflammatory cascade,
resulting in initiation of various degenerative diseases
and autoimmune disorders [15]. Therefore, these antiox-
idants have variety of other biological responses, because
of their indirect influence on inflammatory and immu-
nity pathway. To name a few, these includes eugenol,
gallic acid and quercetin [16-19].
As we have already reported the antioxidant property
of PT tuber extract [20], so here its active principle has
been isolated and the role of inflammation has been
explored. Since alcoholic fraction of PT tuber had
shown most potent FR scavenging potential, therefore it
was subjected to column chromatography and the
isolated compounds were tested for their antioxidant
potential and one of its most active compounds was
characterized by spectral analysis. Its property was com-
pared with its mother extract in terms of their EC50.
Further, its anti-inflammatory property was explored by
monitoring its inhibitory effect on LPS (Lipopolysac-
charide) induced expression of inducible nitric oxide
synthase (iNOS) and release of nitric oxide (NO) in the





(ABTS*), Deoxyribose, were purchased from Sigma
Aldrich Co. USA. Nitrobluetetrazolium (NBT), Ribofla-
vin, L-methionine, thiobarbituric acid, Ethylenediamine
tetra acetic acid (EDTA) were purchased from Hi-Media
Ltd, ferric chloride anhydrous (FeCl3) ascorbic acid,
trichloro acetic acid, potassium persulfate Vitamin C
were purchased from Merck Ltd. All the other reagents
were of analytical grade.
Isolation and characterization of Tuberosin
The root-tubers of Pueraria tuberose were purchased
from local market and its authenticity was rechecked on
pharmacognostical parameters. Its voucher specimen was
persevered in the dept. (No. YBT/MC/12/1-2007). The
dried root-tuber -powder was successively extracted with
hexane and then with ethanol in a soxhlet extractor. The
solvent free alcoholic extract (yield-12-18% w/w) was
saved for column chromatography. 8 g of this extract was
separated over silica gel column (80 × 4 cm) and eluted
with organic solvent with increasing polarity. The ethyl
acetate fraction was subjected to re-chromatography on a
smaller silica gel column (30 × 1.5 cm) by using benzene:
ethyl acetate (7:3) as elution solvent. The isolated com-
pound was re-crystallized from benzene, which furnished
white crystals, m.p. 271-272°C. Its purity was confirmed
by thin layer chromatography on silica gel G plate, where
it showed single spot of Rf value 0.45 with solvent, Ben-
zene: Chloroform (6:4). The spectral data of the isolated
compound (UV, IR and NMR) were compared with the
data of other compounds, isolated from PT extract and
reported in the literature [11]. Based on similarity, this
biologically active isolated compound was identified as
5 hydroxy 3,4,7,3’,4’ pentamethoxy flavone (Tuberosin).
2. Assay of antioxidant property
a. ABTS* radical scavenging activity
ABTS* radical scavenging activity of tuberosin was
determined according to Re et al. [21], where ABTS*
radicals were pre-generated by mixing solutions of
ABTS* (14 mM) and potassium persulphate (4.9 mM).
After mixing different concentrations of the test com-
pound with the ABTS* solution, the reduction in degree
of absorbance was recorded at 734 nm.
b. Lipid peroxidation assay
Lipid Peroxidation assay was carried out by modified
method to measure thiobarbituric acid-reactive sub-
stances (TBARS) [22], where FeSO4 was used to induce
lipid peroxidation in egg yolk homogenates [23]. The
pink colour, developed after heating the reaction
mixture in water bath for 1 h, was read at 532 nm.
c. Superoxide radical scavenging property
Superoxide radical scavenging property was assessed by
monitoring the capacity of test compounds to scavenge
instantly generated superoxides, through riboflavin
mediated photosensitive reaction. The added NBT
solution reacted with superoxide radicals and rate of
formation of its coloured product was monitored at
560 nm [24].
d. Hydroxyl radical scavenging property
Similarly, hydroxyl radical scavenging potential was
measured by Non Site-specific hydroxyl radical-
mediated 2-deoxy-D-ribose degradation. Here, the reac-
tion was carried out in presence of FeCl3 and EDTA.
Here, its complex reacted with H2O2 in presence of
ascorbic acid to produce OH radicals, which degraded
the deoxyribose to a coloured end product, which was
monitored at 532 nm. Finally to assess the metal chelat-
ing property of the test material, the Site-specific hydro-
xyl radical-mediated 2-deoxy-D-ribose degradation was
monitored, where the above reaction was carried out in
absence of EDTA. The difference in the readings of the
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above 2 reactions were considered as degree of metal
chelation [25].
3. Effect on NO production
Inbred male rats of Charls foster (CF) strain of matched
age and weight were purchased from the central animal
house of Institute of Medical Sciences and acclimatized
in our laboratory conditions for 7 days. On the experi-
mental day, the rats were anaesthetized by injecting
ketamine and 10 ml of sterile ice-cold phosphate buffer
saline, devoid of calcium and magnesium ions was
injected in to the peritoneal cavity to each rat, through
a syringe [26]. The abdomen was squeezed for 5 min,
and then the peritoneal fluid was aspirated out. It was
centrifuged and the cell pellet was washed 2 times with
serum free RPMI-1640 media to harvest the macro-
phages. This cell preparation was finally suspended in a
known volume of complete RPMI-1640 media supple-
mented with 5% fetal calf serum (FCS). The isolated
macrophages were counted by trypan blue exclusion
method in haemocytometer and appropriately diluted to
have 1 × 104 cells in 200 μl, which was taken in each
cavity of 96 well culture plate. The plate was incubated
for 2 hr at 37°C in 5% CO2 atmosphere to attach the liv-
ing macrophages [27,28] and then culture supernatant
was replaced with fresh complete media. The attached
macrophages were used for various experiments as
described in respective tables. All tests were carried out
in triplicate. In one set only drug vehicle (0.1% DMSO)
was added, in another set, quercetin was added as posi-
tive control and in test wells, different concentrations of
tuberosin were added. After pre-incubation for 30 min,
LPS (20 ng/ml) was added to each well, mixed and incu-
bated overnight for 17 hours to induce nitric oxide
(NO) production. Next day, accumulated nitrite in the
culture supernatant was monitored by using Griess
reagent [29] (1% sulfanilamide/0.1% naphthalene dia-
mine dihydrochloride 2.5% H3PO4). Absorbance was
read at 550 nm in an ELISA plate reader (Multiscan). It
is an indirect method to measure the accumulated
nitrite in the culture supernatant, which reflects the
concentration of released nitric oxide. The EC50 value of
isolated compound (concentration of sample required to
inhibit 50% response of LPS for NO production) for
each parameter were determined by statistical formula,
given below in the method section.
4. Effect on iNOS expression by Western blot Analysis
After removing the culture supernatant for nitrite esti-
mation, the attached macrophages were washed with
PBS and then lysed by adding 200 μl lysis buffer (20
mM Tris-Buffer (pH = 7.4), containing 0.25 sucrose,
EDTA (1 mM), PMSF (100 μg ml−1), aprotinin (10 μg
ml−1), leupeptin (10 μg ml−1). The protein of this cell
lysate was estimated by Bradford method [30] and its 20
μg protein was run in each lane on 8% sodium dodecyl
sulphate-polyacrylamide gel electrophoresis (SDS-PAGE)
[31]. The separated protein bands were transferred to
nitrocellulose membrane by electro-blotting, washed
with TBS (Tris-buffered saline) containing 0.05% (v/v)
Tween 20 and blocked with 5% (wt/vol) dried non-fat
milk in TBS for 2 hrs. Finally, the blot was incubated
with rabbit polyclonal anti-iNOS antibody (SC650, Santa
Cruz Biotechnology, 1/1000 in TBS-Tween-20 buffer) at
4°C overnight and visualized by alkaline phosphatase-
conjugated anti-rabbit IgG as the secondary antibody.
DAB (diamminobenzidine) was used as substrate [32].
The intensity of bands was analyzed by image analyzer-
2254. The equal loading of sample in each lane was con-
firmed by monitoring the expression of ß-actin.
5. Statistics
All data were expressed as means ± SD. Pearson’s corre-
lation analysis (SPSS 7.5 for Windows, SPSS Inc.) was
used to test for the significance of relationship between
the concentration and percentage inhibition at a p < 0.05
significance level. The EC50 of for different parameters
were calculated by using the following formula
Y A BX50 = +
Where, A = Mean of × - B (predicted Y value=, 50%)
B = ∑ − ∑ ∑
∑ − ∑
X Y X Y N
Y Y N
. ( )( )/
( / )2 2
X = independent variable (Concentration of Drug)
Y = dependent variable (% inhibition)
Results
(1) Characterization of Tuberosin
The spectral data of the isolated compound for UV, IR,
1H-NMR, and 13C NMR (Table 1) were compared with
the data available in the literature and based on the
similarity, the isolated compound was identified as was
tuberosin (figure 1).
(2). ABTS* assay
Tuberosin scavenged the pre-generated ABTS* radicals
in concentration-dependent manner, with EC50 values as
70 ng/ml, which was lower as compared to its mother
extract (alcoholic fraction of PT- 320 μmug/ml). The
difference was in the range of 44.71 fold (Table 2).
(3). Superoxide scavenging assay
Tuberosin also scavenged the instantly generated super-
oxide radicals in a concentration-dependent manner
with EC50 value at 156 μmug/ml (Table 2), which was
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1.5 times lower than it’s alcoholic mother extract
(240 μmug/ml).
(4). Lipid Peroxidation Assay
There was significant and concentration-dependent inhi-
bition by tuberosin on FeSO4 induced lipid peroxidation
(Table 3). Tuberosin had 7.95 fold lower EC50 value
(98 μmug/ml) as compared to the alcoholic extract of
PT (780 μmug/ml).
(5). Non-site specific Hydroxyl radical scavenging assay
(With EDTA)
Tuberosin was found to be the more potent hydroxyl
radical scavenger with EC50 values of (32 μmug/ml),
which was 9.6 time lower than it’s alcoholic fraction
(EC50 310 μmug/ml) (Table 4).
(6) Site specific Hydroxyl radical scavenging assay
(Without EDTA)
Further in the case of Site specific Hydroxyl radical
scavenging assay (without EDTA), EC50 values of tuber-
osin was at 28 μmug/ml, which was lower than the
value obtained in case of non site specific reaction
(described above), suggesting its additional role as metal
chelation (Table 4).
(7) Effect of tuberosin on LPS induced NO production and
iNOS-protein expression in macrophages
Tuberosin significantly inhibited LPS induced release of
nitric oxide (NO) by macrophages in concentration-
dependent manner (Table 5). It also inhibited the accu-
mulation of iNOS proteins in the attached macrophages
(Figure 2).
Discussion
Various pure isolated phytochemicals or plant extracts
having natural cocktail of various poly-phenolics, have
shown antioxidant and anti-inflammatory property
[33,34]. They are also in use for the management of age
related chronic diseases such as diabetic complications
[35], atherosclerosis [36] and inflammation [37], as food
supplement or as add-on therapy with conventional
medicine.
The powder of PT root-tubers are already in clinical
use by Ayurvedic physicians of Indian system of medi-
cine [6], but neither its mechanism of action nor the
active principle for its antioxidant and anti-inflammatory
property has been explored so far. Interestingly, our data
has helped in characterizing the isolated compound as
tuberosin, which has already been reported [11], but no
biological activity related to LPS induced changes, has
been available in the literature.
Tuberosin has exhibited direct FR trapping capacity in
a chemical reaction system, however, variability in its
potency towards various free radical species, could be
because of the difference in the electron potential of
these free radical species [38]. Further, the Fe induced
lipid peroxidation in presence of ascorbic acid, is an
example non-enzymatic process (Fe++/ascorbic acid),
therefore, the anti-lipid-peroxidative property of tubero-
sin, described above, indicates its total antioxidant capa-
city. As it has also shown metal chelation property
along with direct FR trapping property, therefore the net
response of inhibition towards lipid peroxidation could
be a combined effect of these 2 responses.
Table 1 Analytical data of isolated compound (Tuberosin; 5hydroxy 3,6,7,3’4’ pentamethoxy flavone)
Melting point 271-72°C
TLC pattern Solvent system: benzene:ethyl acetate (7:3)
RF value: 0.45
UV(MeOH) (log ε): 255(4.26),
274 (4.18) and
346 nm (4.21)
IR (KBr) cm-1 3480, 1664 and 1559
1H NMR (CDCl3) δ 12.62 (1 H, s, O - H), 7.75 (2 H, m, 2’ - H and 6’ - H), 7.01 (1 H, d, J = 9.0 Hz, 5’ - H), 6.51 (1 H, s, 8 - H), 3.98 (9 H, s, 3 ×
OCH3), 3.93 (3 H, s, OCH3) and 3.87 (3 H, s, OCH3).
13C NMR δ 158.7 (C - 2), 132.4 (C - 3), 178.8 (C - 4), 155.7 (C-5), 138.8 (C-6), 152.7 (C-7), 90.3 (C- 8), 151.5 (C-9), 106.6 (C-10), 122.9 (C-1’),
111.7 (C-2’), 148.9 (C-3’), 152.2 (C-4’), 111.6 (C-5’), 122.1 (C-6’), 60.7 (6-OCH3), 56.1 (7-OCH3), 60.1 (3-OCH3), 56.2 (3’ - OCH3) and
55.9 (4’ - OCH3).
Figure 1 Structure of tuberosin.
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Table 2 Effect of tuberosin on pre-generated ABTS* radical and superoxide radical scavenging property
Concentration of
tuberosin (μM)
% decrease in absorbance at 734 nm (mean ± S.D.) for
ABTS* radical scavenging
% decrease in absorbance at 560 nm (mean ± S.D.) for
SO radical scavenging
50 8.42 ± 0.99* 5.78 ± 0.46**
125 24.09 ± 0.33* 18.98 ± 0.76**
200 45.16 ± 0.89* 27.89 ± 0.55**
250 60.00 ± 1.05* 54.78 ± 0.87**
375 77.25 ± 1.06* 67.11 ± 0.77**
500 93.08 ± 0.63 * 83.44 ± 0.63**
775 97.24 ± 0.89* 97.24 ± 1.22**
EC50 198.67 μmuM 205.11 μmuM
EC50 of Vit C- 220 μmuM, EC50 for quercetin- 0.60 μmuM
n = 3, Level of significance: p* < 0.1 and p** < 0.001
Table 3 Inhibition of lipid peroxidation induced by FeSO4 using egg yolk homogenates
Concentration of tuberosin (mM) Absorbance at 532 nm
(mean ± SD)




12 0.320 ± .021* 7.08 ± 1.30
18 0.283 ± .020* 17.89 ± 1.00
25 0.248 ± .018** 27.98 ± 1.42
30 0.198 ± .015** 42.74 ± 0.96
40 0.131 ± .010** 62.05 ± 1.50
45 0.073 ± .002** 78.76 ± 1.16
50 0.049 ± .001** 85.83 ± 1.30
n = 3 EC50 of tuberosin- 49.22 mM, EC50 for quercetin- 0.60 μmuM
@
Level of significance: p* < 0.1 and p** < 0.001. @Reference 18
Table 4 Effect of tuberosin in the deoxyribose assay in the presence of EDTA (non-site specific) to assess the Hydroxyl
radical scavenging activity and absence of EDTA (site specific) to assess metal chelation property
Concentration of tuberosin (mM) Absorbance at 532 nm (mean ± S.D) % decrease in absorbance
(mean ± SD)
(Non site specific) (Site specific) (Non site specific) (Site specific)
Normal 0.310 ± .018 0.515 ± .028 – –
Blank 0.288 ± .017 0.485 ± .022 – –
0.25 0.280 ± 0.014* 0.400 ± .024* 2.60 ± 0.94 17.54 ± 1.25
0.50 0.256 ± .015* 0.356 ± .021** 11.22 ± 0.97 26.54 ± 1.15
0.75 0.235 ± .013** 0.311 ±.020** 18.35 ± 0.88 35.82 ± 0.91
1.00 0.199 ± .012** 0.271 ± .018** 30.73 ± 1.08 44.08 ± 0.96
1.25 0.156 ± .011** 0.190 ± .011** 45.94 ± 0.94 60.80 ± 0.94
1.80 0.125 ± .010** 0.119 ± .008** 56.72 ± 1.14 75.51 ± 0.99
2.50 0.092 ± .007** 0.01 ± .001** 67.94 ± 0.67 98.04 ± 0.62
n = 3; EC50 of tuberosin: Non site specific assay = 1.14 mM and site specific assay = 0.918 mM; EC50 (μmuM) for quercetin - Non site specific assay 0.80 and site
specific assay- 0.50; Level of significance: p* < 0.1 and p** < 0.001.
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Tuberosine has shown lower EC50 value on all tested
parameters than its mother alcoholic extract, which sug-
gests its higher potency, and therefore it could be consid-
ered as its active principle. However, it has been found to
be significantly less potent than quercetin, which could
be because of structural difference in these two com-
pounds. It has been documented earlier that number and
position of hydroxyl groups in the flavones ring, regulates
its antioxidant potential and the presence of 3-OH makes
the compound more potent than that of 5-OH group
[39]. From the structural comparison of these 2 com-
pounds, it is clear that tuberosine has 5-OH group,
where as quercetin has 3-OH group. Thus, the higher
potency of quercetin over tuberosin could be explained.
Measurement of inhibitory property of a test compound
against LPS induced NO release is one of the standard
models to explore anti-inflammatory potential of any test
drug. LPS is known to induce iNOS through activation of
NF-kB and this process involves free radicals (FR) in its
early steps, just after interacting with its Toll-like receptor
(TLR) [40,41]. Therefore, free radical scavengers have been
reported earlier to inhibit this process and our data has also
shown concentration-dependent inhibition of LPS induced
NO release. This trapping capacity of tuberosin, for variety
of free radical species and also for metal chelation property
has been found in our in vitro testing on a chemical test
model. Thus, it could be suggested that tuberosin might be
acting on the initial steps of the signaling cascade of LPS
induced NO production, but it is still not clear, whether it
is directly inhibiting the activity of iNOS enzyme or it is
suppressing the synthesis of this enzyme.
To target this question, we explored the effect of
tuberosin on iNOS protein in macrophages, when
exposed to LPS. Interestingly, our data show that tuber-
osin significantly inhibited the iNOS protein in western
blot analysis. The results suggested that tuberosin is
inhibiting the expression of iNOS genes, as amount of
iNOS proteins was significantly lower in tuberosin pre-
treated cells in concentration dependent manner.
Conclusion
From the above experimental results, it could be sug-
gested that tuberosin is one of the active principles of
Table 5 Effect of tuberosin on LPS induced NO production and iNOS expression by attached rat peritoneal
macrophages.
Concentration of tuberosin (ng/ml) NO production (μg/104cells) Pixel value of iNOS bands in western blot
Normal Cells 10.11 ± 1.043 -
Only LPS (20 ng/ml) 39.89 ± 1.983 16023
LPS(20 ng/ml)+Tuberosin(ng/ml) -
100 38.09 ± 1.933 15878
200 36.09 ± 1.862** -
300 27.02 ± 1.698** 10678
400 21.16 ± 1.829* -
500 13.04 ± 1.904* -
600 10.09 ± 1.898* 5082
LPS + Quercetin(50 ng/ml) 9.98 ± 1.041 4223
EC50 of tuberosin 399.68 ng/ml -
EC50 of quercetin 190 ng/ml -
Values were significant (p* < 0.1, p** < 0.001) when compared with experimental control.
Figure 2 Effect of different concentrations of Tuberosin on LPS
induced iNOS expression in attached rat peritoneal
macrophages. The macrophages were pretreated with quercetin
and tuberosin as given below for 30 minutes and then LPS was
added (20 ng/ml) and incubated for 17 hrs. The normal cells were
exposed to 0.1% DMSO without any LPS. Lane-1: LPS(20 ng/ml),
Lane-2: Normal cells. Lane3:LPS+Quercetine(50 ng/ml), Lane4:LPS
+Tuberosine(100 ng/ml), Lane-5: LPS+Tuberosine(300 ng/ml), Lane-6:
LPS+Tuberosine(600 ng/ml). The bars depict densitometric analysis
of western blot (given in the inset). This picture represents one out
of total three experiments carried out separately.
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Pueraria tuberose for its claimed antioxidant property.
The tuberosine has direct scavenging potential for vari-
ety of free radicals with preference to ABTS* radicals
followed by hydroxyl radicals and then superoxide radi-
cals. It has additional metal chelation property. Tubero-
sin has potential to inhibit LPS induced NO production
in concentration-dependent manner, which is due to
inhibition in the expression of iNOS proteins.
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